Here we investigated the effects of mineralocorticoid in the regulation of catecholamine biosynthesis using rat pheochromocytoma PC12 cells. Expression of mineralocorticoid receptor (MR) was confirmed in undifferentiated PC12 cells. Aldosterone stimulated dopamine production by PC12 cells without any increase in cAMP activity. Aldosterone-induced dopamine accumulation was enhanced in accordance with the increase in the rate-limiting enzyme tyrosine hydroxylase (TH). Blocking MR with eplerenone suppressed aldosterone-induced increases of TH mRNA and dopamine production. A glucocorticoid receptor (GR) antagonist, RU-486, attenuated dexamethasone-but not aldosterone-induced TH expression. Cycloheximide reduced both aldosterone-and dexamethasone-induced TH mRNA. A SAPK/JNK inhibitor, SP600125, suppressed aldosterone-induced TH mRNA expression; however, the aldosterone-induced TH expression was not affected by inhibition of ERK1/2, p38-MAPK, Rho-kinase, PI 3-kinase, and PKC. It was of note that cotreatment with eplerenone and SP600125 restored aldosterone-induced TH mRNA expression to basal levels. To investigate the involvement of bone morphogenetic protein (BMP) actions in aldosterone-induced catecholamine production, we examined the effects of BMP-4 and BMP-7, which are expressed in the adrenal medulla, on catecholamine biosynthesis. BMP-4 preferentially enhanced aldosterone-induced TH mRNA and dopamine production, although BMP-4 alone did not affect TH expression. The BMP-4 enhancement of aldosterone-induced TH expression was not observed in cells treated with eplerenone. BMP-4 did not affect MR expression of PC12 cells; however, it did enhance aldosterone-induced SAPK/JNK phosphorylation. Inhibition of SAPK/JNK or Rho suppressed BMP-4 enhancement of aldosterone-induced TH expression. Collectively, our findings demonstrate that aldosterone stimulates catecholamine biosynthesis in adrenomedullar cells via MR through genomic action and partly through nongenomic action by Rho-SAPK/JNK signaling, the latter of which is facilitated by BMP-4. A functional link between MR actions and endogenous BMP may be involved in the catecholamine production.
manner due to their close embryological structure (6, 54) . Endogenous glucocorticoids are well known to induce catecholamine biosynthesis by stimulating catecholamine-synthesizing enzymes through the cortico-medullary portal system (69) . Earlier, we reported the presence of bone morphogenetic protein (BMP) system in the adrenal and a functional cross-talk between glucocorticoid and BMP system in regulating catecholamine synthesis in adrenomedullar cells (32) .
BMPs belong to the transforming growth factor-␤ superfamily and have been demonstrated to exert a variety of physiological actions in various endocrine organs, including ovary (56) , pituitary (45, 49, 64) , thyroid (62) , and adrenal (28, 32, 61) . It has been shown that key components of the BMP system are expressed throughout neural development in complex patterns for fine-tuning various developmental stages in an autocrine and/or paracrine manner (41) . BMP-4 and BMP-7 are expressed in the dorsal aorta and direct sympathetic neuronal differentiation into the adrenergic characteristics (51) . Furthermore, BMP-4 and BMP-7 induce tyrosine hydroxylase (TH)-immunoreactive adrenergic phenotype in cultures of avian neural crest cells (67, 68) . However, the physiological roles of BMPs in regulation of neuroendocrine dynamics after phenotypic maturation of sympathoadrenal neurons remain to be elucidated.
As for the interrelationship between aldosterone and dopamine in the adrenal, control of adrenal aldosterone production by dopamine is widely recognized and established (9, 20, 21) . A dopamine antagonist stimulates aldosterone secretion, which can, in turn, be blocked by dopamine. Dopamine also inhibits angiotensin II-and potassium-induced aldosterone secretion from bovine adrenal cells (15, 40) . The dopamine actions suppressing aldosterone are likely to occur via the dopamine D2 receptor (44) , although adrenal cortex expresses both D1 and D2 receptors (2, 4, 5) . The dopamine D1 receptor appears to be linked to the stimulation of adenylate cyclase, whereas the D2 receptor is coupled in an inhibitory manner to cAMP synthesis (43) .
The effects of aldosterone on neighboring chromaffin cells, however, remain poorly understood, although mineralocorticoids are major hormones produced from adrenal cortex. Recent studies have shown that aldosterone exerts various biological actions not only by classical genomic actions through regulation of nuclear gene transcription and protein synthesis via mineralocorticoid receptor (MR) but also by rapid, potentially nongenomic responses (17) . In epithelial cells, MR is protected from excessive cortisol by coexpressing 11␤-hydroxysteroid dehydrogenase type 2 (11␤-HSD2), which converts active cortisol to inactive cortisone in vivo (14, 18) , whereas in nonepithelial tissues without expression of 11␤-HSD2, MR is recognized to be occupied by overwhelmingly existing cortisol rather than aldosterone in vivo. Given the finding that patients with primary aldosteronism exhibit higher plasma dopamine levels compared with essential hypertensive patients (27, 33) , the possible influence of aldosterone on adrenal medullar functions can be speculated.
In the present study, we investigated aldosterone actions on catecholamine biosynthesis utilizing rat adrenomedullar cell line PC12. The PC12 cell line is a clone of cells derived from a rat adrenal medullary tumor. PC12 cells exhibit many properties of adrenal medullary chromaffin cells, including catecholamine synthesis, storage, and secretion (24) . Catecholamine biosynthesis, in which tyrosine is converted into dopamine, is initially catalyzed by TH to produce 3,4-dihydroxyphenylalanine (DOPA). DOPA is then converted to dopamine by DOPA decarboxylase (DDC), also called aromatic L-amino acid decarboxylase. Dopamine-␤-hydroxylase (DBH) converts dopamine to noradrenaline. Since the expression of MR was confirmed in rat pheochromocytoma-derived undifferentiated PC12 cells, here we investigated the aldosterone-induced actions involved in the catecholamine production by PC12 cells. A possible functional cross-talk between aldosterone and BMP system in regulation of catecholamine production was uncovered.
MATERIALS AND METHODS
Reagents and supplies. Dulbecco's modified Eagle's medium (DMEM), penicillin-streptomycin solution, D-aldosterone, cycloheximide, dimethylsulfoxide, dexamethasone, 3-isobutyl-1-methylxanthine (IBMX), Clostridium difficile toxin B, and geranylgeranyl transferase I inhibitor (GGTI)-298 were purchased from Sigma-Aldrich (St. Louis, MO). Recombinant human BMP-4 and BMP-7 were purchased from R&D Systems (Minneapolis, MN). U-0126, SB-203580, myristoylated protein kinase C peptide inhibitor (PKCI), and LY-294002 were purchased from Promega (Madison, WI), SP600125 was from Biomol Laboratory (Plymouth Meeting, PA), and Y-27632 was from Calbiochem (San Diego, CA). Eplerenone was provided by Pfizer (New York, NY). Pioglitazone and fenofibric acid were provided from Takeda Chemical Industries (Osaka, Japan) and Kaken Pharmaceutical (Tokyo, Japan), respectively. PC12 cells were kindly provided by Dr. Isao Date, Department of Neurosurgery at Okayama University, Okayama City, Japan. Normal rat adrenal tissues were obtained from male SpragueDawley rats, spontaneously hypertensive rats, and Wistar-Kyoto rats (Charles River Laboratories, Wilmington, MA). The protocol was conducted in accordance with an animal use protocol approved by our institutional committee.
Cell culture and catecholamine analysis. PC12 cells were maintained in DMEM supplemented with 10% fetal calf serum (FCS), 10% horse serum (HS), penicillin, and streptomycin (Sigma-Aldrich) at 37°C in a 5% CO 2 humidified atmosphere. The culture medium was changed twice/wk, and cultures were passaged at ϳ80% confluence. Changes in cell morphology were monitored after treatments with aldosterone, dexamethasone, pioglitazone, and fenofibric acid using an inverted microscope with chamber slides (Nalge Nunc International, Naperville, IL). PC12 cells (1 ϫ 10 5 viable cells) were precultured in DMEM containing 1% FCS and 1% HS for 24 h and then treated with the indicated concentrations of aldosterone, dexamethasone in combination with the selective MR antagonist eplerenone, BMP-4, and BMP-7. The culture medium was collected after 24-h culture, and the catecholamine levels, including dopamine, noradrenaline, and adrenaline, were determined by high-performance liquid chromatography (HPLC; Tosoh Analysis and Research Center, Shunan, Japan).
RNA extraction, RT-PCR, and quantitative real-time PCR analysis. PC12 cells (3 ϫ 10 5 viable cells) were precultured in DMEM containing 1% FCS and 1% HS in 12-well plates, and then cells were treated with indicated concentrations of aldosterone, dexamethasone, BMP-4, and BMP-7 in combination with the selective MR antagonist eplerenone, the GR antagonist RU-486, and various chemical inhibitors, including cycloheximide, U-0126, SB-203580, SP600125, PKCI, LY-294002, and Y-27632. After 24-h culture the medium was removed, and total cellular RNAs were extracted using TRIzol (Invitrogen), subsequently quantified by measuring absorbance at 260 nm, and stored at Ϫ80°C until assay. Total RNA of adrenal tissues was also extracted using TRIzol from 7-wk-old male Sprague-Dawley rats. The expression of MR, GR, catecholamine synthases (TH, DDC, and DBH), 11␤-HSD2, BMP ligands, BMP receptors, and Smads was detected by RT-PCR analysis. The extracted RNA (1 g) was subjected to an RT reaction using the first-strand cDNA synthesis system (Invitrogen) with random hexamer (2 ng/l), reverse transcriptase (200 U), and deoxynucleotide triphosphate (dNTP; 0.5 mM) at 42°C for 50 min and 70°C for 10 min. Subsequently, hot-start PCR was performed using MgCl 2 (1.5 mM), dNTP (0.2 mM), and 2.5 U Taq DNA polymerase (Invitrogen). Oligonucleotides used for PCR were custom-ordered from Invitrogen. PCR primer pairs were selected from different exons of the corresponding genes to discriminate PCR products that might arise from possible chromosome DNA contaminants. The primer pairs for rodent BMP ligands, BMP receptors, Smads, the housekeeping gene ribosomal protein L19 (RPL19), and catecholamine synthase genes, including TH, DDC, and DBH, were selected as we reported (32, 45, 63) . For GR, MR, and 11␤-HSD2 genes, the following sequences were used: GR, 1895-1915 and 2171-2191 from GenBank accession no. X04435; MR, 2978-2999 and 3219-3240 from M36074; and 11␤-HSD2, 622-642 and 891-911 from NM_017081. The PCR product sizes are as follows: BMP-4, 241 bp; BMP-7, 287 bp; activin receptor-like kinase (ALK)2, 483 bp; ALK3, 510 bp; ALK6, 456 bp; BMPRII, 522 bp; ActRIIA, 492 bp; ActRIIB, 271 bp; TH, 445 bp; DDC, 387 bp; DBH, 364 bp; GR, 297 bp; MR, 263 bp; 11␤-HSD2, 290 bp; and RPL19, 195 bp. The aliquots of PCR products were electrophoresed on 1.5% agarose gels and visualized after ethidium bromide staining. For the quantification of TH, MR, BMP-4, BMP-7, and RPL19 mRNA levels, real-time PCR was performed using LightCycler-FastStart DNA master SYBR Green I system (Roche Diagnostics, Tokyo, Japan) under conditions of annealing at 60°C with 4 mM MgCl2, following the manufacturer's protocol. Accumulated levels of fluorescence were analyzed by the second derivative method after the melting-curve analysis (Roche Diagnostics), and then the expression levels of target genes were standardized by RPL19 level in each sample.
Measurement of cAMP production. To assess effects of aldosterone and dexamethasone on cAMP synthesis, PC12 cells (1 ϫ 10 5 viable cells) were cultured in 96-well plates with DMEM containing 10% FCS and 10% HS for 24 h. The medium was then changed to DMEM containing 1% FCS and 1% HS and subsequently treated with the indicated concentrations of dexamethasone and aldosterone in the presence of 0.1 mM IBMX (a specific inhibitor of phosphodiesterase activity). After 24-h culture, the supernatant of the culture medium was collected and stored at Ϫ80°C until assay. The extracellular contents of cAMP were determined by enzyme immunoassay (Assay Designs, Ann Arbor, MI) after the acetylation of each sample with assay sensitivity of 0.039 nM.
Western immunoblot analysis. PC12 cells (1 ϫ 10 5 viable cells) were precultured in 12-well plates in serum-free DMEM. After 24-h preculture, aldosterone (100 nM) was added to the culture medium either alone or in combination with SP600125 (10 M) and BMP-4 (100 ng/ml). After 10-, 30-, and 60-min stimulation with hormones and/or growth factors, cells were solubilized in 100 l of RIPA lysis buffer (Upstate Biotechnology, Lake Placid, NY) containing 1 mM Na 3VO4, 1 mM NaF, 2% SDS, and 4% ␤-mercaptoethanol. After stimulation with hormones and/or growth factors for indicated periods, the membrane fraction of PC12 cells was extracted by ProteoExtract Native Membrane Protein Extraction Kit (Calbiochem). The cell lysates and the membrane fractions were then subjected to SDS-PAGE/immunoblotting analysis, as we reported previously (28, 48) , using anti-phospho-and anti-total-stress-activated protein kinase (SAPK)/c-Jun NH 2-terminal Immunofluorescence microscopy. For immunofluorescence study, PC12 cells were precultured in serum-free DMEM using chamber slides (Nalge Nunc International). Cells at ϳ50% confluency were treated with BMP-4 (100 ng/ml) for 1 h. Cells were then fixed with 4% paraformaldehyde in PBS, permeabilized with 0.5% Triton X-100 in PBS at room temperature, and washed three times with PBS. The cells were then incubated with anti-phospho-Smad1,5,8 antibody (Cell Signaling Technology) for 1 h and washed three times with PBS. Cells were then incubated with Alexa fluor 488 anti-rabbit IgG (Invitrogen) in a humidified chamber for 1 h and washed with PBS, and then stained cells were visualized under fluorescent microscope. Immunohistochemistry study. For the immunohistochemical analyses, 4-m-thick sections of formalin-fixed and paraffin-embedded adrenal tissues obtained from 12-wk-old male spontaneously hypertensive rats and Wistar-Kyoto rats were dewaxed and rehydrated, and antigen retrieval was performed by heating for 10 min in a 10-mM citrate buffer at pH 6.0. The sections were reacted with gout polyclonal antibody for BMP-4 (R&D Systems), diluted at 15 g/ml for 16 h at 4°C, and then subsequently stained using the universal immunoperoxidase polymer method with the Histofine staining kit (Nichirei, Tokyo, Japan) according to the manufacturer's protocol. Positive reaction was visualized with 3,3Ј-diaminobenzidine tetrahydrochloride followed by counterstaining with hematoxylin. For negative controls, normal goat antibody was used instead of primary antibodies, and no specific immunoreactivity was detected in these sections.
Statistical analysis. All results are shown as means Ϯ SE of data from at least three separate experiments, each performed with triplicate samples. Differences between groups were analyzed for statistical significance using ANOVA with Fisher's protected least significant difference test (StatView 5.0 software; Abacus Concepts, Berkeley, CA). P values Ͻ0.05 were accepted as statistically significant.
RESULTS
We first confirmed the mRNA expression of catecholamine synthases, including the rate-limiting enzyme TH, DDC, and DBH, by RT-PCR in PC12 cells as well as in the rat whole adrenals and medullar tissues (Fig. 1A ). PC12 cells expressed MR and GR, as did the whole adrenal and adrenomedullar tissues. In addition, 11␤-HSD2 expression was also detected in PC12 cells and in rat whole adrenals and medullar tissues (Fig.  1A) . The protein expression of MR was further confirmed by immunoblotting analysis in undifferentiated PC12 cells. The expression of MR protein (ϳ107 kDa) was detected in PC12 cells treated with dexamethasone (1 M), aldosterone (100 nM), and a peroxisome proliferator-activated receptor (PPAR)␣ agonist, fenofibric acid (1 M) (Fig. 1B) . However, the MR protein expression was nearly undetectable in differentiated PC12 cells treated with a PPAR␥ agonist, pioglitazone (1 M) . No specific differences of the morphological changes indicating neural differentiation were shown between PC12 cells treated with dexamethasone (1 M), aldosterone (100 nM), and fenofibric acid (1 M). However, PC12 cells treated with a PPAR␥ agonist, pioglitazone (1 M), showed a marked differentiation with typical neurite outgrowth (16) . The expression levels of internal control actin (42 kDa) were not changed regardless of the treatment (Fig. 1B) . To investigate the involvement of BMP actions in aldosterone-induced catecholamine production, we examined the presence of key components of the BMP system, including BMP ligands, BMP type I and type II receptors, and Smads in PC12 cells and rat adrenal tissues. As shown in Fig. 1C , PC12 cells and adrenal medulla clearly expressed BMP-4 and -7, ALK-2 and -3, ActRIIA, ActRIIB, BMPRII, receptor-regulated Smad1, -2, -3, -5, and -8, common Smad4, and inhibitory Smad6 and -7. Furthermore, BMP-4 protein expression was detected by immunohistochemical analysis in rat adrenomedullar tissues (Fig. 1D) .
We next studied effects of aldosterone or dexamethasone on catecholamine biosynthesis in PC12 cells. Dopamine secretion attained to ϳ200 pg/ml in the conditioned medium during 24-h culture, although the secreted levels of noradrenaline and adrenaline by PC12 cells were not attained to detectable ranges. On the basis of our earlier optimization regarding the determination of catecholamine production by undifferentiated PC12 cells, PC12 cells were cultured in medium containing 1% FCS and 1% HS (32) . Culturing PC12 cells in medium containing 1% serum attained the highest dopamine secretion into the medium with arrested cell proliferation. Time course experiments revealed that dopamine levels saturate after 48-h culture and the least variable at the 24-h time point. In this culture condition, aldosterone and dexamethasone increased dopamine production in a concentration-responsive manner in accumulated medium (Fig. 2A) . In accordance with the increase in dopamine, mRNA of a rate-limiting enzyme for catecholamine production TH was upregulated by aldosterone and dexamethasone (Fig. 2B) . However, accumulated levels of cAMP were not affected by aldosterone or dexamethasone, indicating that cAMP signaling is not directly involved in catecholamine biosynthesis by mineralocorticoids and glucocorticoids in PC12 cells (Fig. 2C) .
The involvement of MR/GR in regulating TH induction was examined to elucidate the mechanisms by which aldosterone induces dopamine production. Eplerenone, a selective MR antagonist, significantly suppressed aldosteronebut not dexamethasone-induced TH mRNA expression (Fig.  3A) . Aldosterone (100 nM)-induced TH mRNA levels were reduced by 15% and 35% in the presence of 100 and 300 nM of eprelenone, respectively. In contrast, RU-486, a GR antagonist, preferentially decreased dexamethasone-induced TH mRNA levels (Fig. 3B) . A translational inhibitor, cycloheximide also decreased aldosterone-and dexamethasoneinduced TH mRNA levels (Fig. 3C) . In addition, the inhibitory effect of eplerenone on aldosterone-induced TH expression was not significantly affected by cotreatment with RU-486 (Fig. 3D) . Likewise, the effects of RU-486 on dexamethasoneinduced TH mRNA were not affected by addition of eplerenone (Fig. 3E) .
There has been accumulating evidence showing that aldosterone also induces rapid activation of intracellular signaling pathways, including mitogen-activated protein kinase (MAPK) (22, 25, 48) , Rho-kinase (60), phosphatidylinositol 3-kinase (PI3K) (39) , and PKC (11, 36) , in a cell-specific manner. To study the functional involvement of the intracellular signaling in PC12 cells, we examined inhibitory effects of MAPK, Rho-kinase, PI3K, and PKC pathways on aldosterone-induced TH mRNA expression. As shown in Fig. 4 , U-0126 and SB-203580, inhibitors for ERK1/2 and p38-MAPK pathways, respectively, did not affect either aldostrerone-or dexamethasone-induced TH mRNA levels. Notably, a SAPK/JNK inhibitor, SP600125, suppressed aldosterone-induced TH mRNA expression in a concentration-dependent manner. In contrast, dexamethasone-induced TH expression was not affected by SP600125 (Fig. 4C) . Rho-kinase inhibitor Y-27632, PI3K inhibitor LY-294002, and a PKCI had no significant effects on aldosterone-or dexamethasone-induced TH mRNA levels. These data suggest that SAPK/JNK signaling is potentially involved in aldosterone-induced TH expression and catecholamine production. Furthermore, treatment with eplerenone (Fig. 5A) or cycloheximide (Fig. 5B ) in combination with a SAPK/JNK inhibitor, SP600125, restored aldosterone-induced TH mRNA expression to the basal levels. Likewise, eplerenone in combination with various concentrations of SP600125 restored aldosterone-induced dopamine production (Fig. 5C ), suggesting that both of the MR-mediated genomic actions and the SAPK/JNK pathway are functionally involved in regulating aldosterone-induced catecholamine production.
We next examined functional roles of BMP-4 and BMP-7 in catecholamine production by PC12 cells. BMP-4 and BMP-7 alone had no significant effects on TH mRNA levels (Fig. 6A) . As shown in Fig. 6B , BMP-4 preferentially enhanced aldosterone-induced TH mRNA expression compared with that induced by dexamethasone. In contrast, BMP-7 had no significant effects on aldosterone-and dexamethasone-induced TH mRNA (Fig. 6C) . BMP-4 enhancement of aldosterone-induced dopamine production was significantly higher than that induced by BMP-7 (Fig. 7A) . In addition, BMP-4 and BMP-7 did not affect the expression levels of MR mRNA and MR protein (Fig. 7, B and C) . Nuclear localization of phosphorylated Smad1,5,8 was demonstrated in PC12 cells stimulated with BMP-4 (Fig. 7D) . Furthermore, Smad1,5,8 phosphorylation induced by BMP-4 has been preserved regardless of the treatments with aldosterone and dexamethasone (Fig. 7D) . Also, the expression of BMP-4 was not affected by the presence of aldosterone or dexamethasone. In contrast, BMP-7 mRNA was reduced in aldosterone-treated PC12 cells (Fig. 7E ). These data imply that endogenous BMP-4 and BMP-4-induced Smad signaling are preserved in the process of aldosterone-induced catecholamine production. Importantly, the BMP-4 enhancement of aldosterone-induced TH expression (Fig. 8A ) and dopamine production (Fig. 8B ) was abrogated by eplerenone treatment, implying that BMP-4 preferentially facilitates aldosterone actions mediated via MR by PC12 cells.
Next, effects of BMP-4 on aldosterone-induced SAPK/ JNK activation were investigated. Aldosterone activated SAPK/JNK phosphorylation during 10-to 60-min observation in PC12 cells, in which SAPK/JNK activation was highest at 30 min after the stimulation (Fig. 9A) . Aldosterone significantly induced p54-SAPK/JNK phosphorylation in PC12 cells, which was further enhanced by BMP-4 treatment (Fig. 9A) . The p54-SAPK/JNK activation induced by aldosterone, as well as that induced by aldosterone in combination with BMP-4, was significantly suppressed in the presence of SP600125. The p46-SAPK/JNK phosphorylation increased in response to the addition of BMP-4. Aldosterone enhanced the BMP-4-induced p46-SAPK/JNK activation in PC12 cells (Fig. 9A) . Thus, aldosterone in the presence of BMP-4 action preferentially stimulated the p54/p46-SAPK/JNK pathway in PC12 cells. Furthermore, involvement of activation of small GTP-binding protein RhoA, an upstream activator for SAPK/JNK pathway (57), was examined in membrane protein fractions of PC12 cells (Fig. 9B) . Both aldosterone and dexamethasone induced RhoA activation, i.e., membrane localization of RhoA protein. BMP-4 preferentially enhanced RhoA activation induced by aldosterone compared with that induced by dexamethasone.
We therefore studied roles of the Rho-SAPK/JNK pathway in the BMP-4 enhancement of aldosterone-induced catecholamine synthesis by PC12 cells (Fig. 10) . As shown in Fig. 10 , left, SP600125 suppressed BMP-4 enhancement of aldosterone-induced TH mRNA levels, indicating that BMP-4 enhances aldosterone-induced catecholamine production through activating SAPK/JNK signaling. Clostridium difficile toxin B, which inactivates membrane Rho proteins by glycosylation modification (31) , inhibited the BMP-4 enhancement of aldosterone-induced TH expression (Fig. 10, middle) , suggesting the functional involvement of Rho proteins in activating TH expression by aldosterone and BMP-4. However, GGTI-298, a geranylgeranyl transferase inhibitor of Rho proteins (37) , failed to suppress the BMP-4 enhancement of aldosterone-induced TH expression (Fig. 10, right) , suggesting that BMP-4 possibly stimulates Rho-SAPK/JNK pathway at the downstream process of geranylgeranylation of cytosolic Rho proteins. Taken together, these findings demonstrate that BMP-4 facilitates MR-mediated actions through activating the Rho-SAPK/JNK pathway, leading to augmentation of aldosterone-induced TH expression and catecholamine production (Fig. 11) .
DISCUSSION
In the present study, we demonstrated that not only glucocorticoids but also mineralocorticoids are involved in regulation of catecholamine biosynthesis in undifferentiated PC12 cells by stimulating dopamine production through the upregulation of TH expression. In adrenomedullary cells, TH is considered to be the rate-limiting enzyme in catecholamine biosynthesis (35) , in which TH activity can be governed by acute and chronic regulatory mechanisms (70) . Acute regulation of TH activity occurs at a posttranscriptional level mainly through the phosphorylation of TH, resulting in activation of the preexisting enzymes. Chronic activation, which can last from minutes to days, is governed through the regulation of TH transcription. Activity of both TH and DBH is regulated by second-messenger mechanisms involving the activation of cAMP, PKA, and PKC in PC12 cells (34) . However, the present results suggest that aldosterone-induced TH expression and catecholamine production are independent of activation of the cAMP-PKA pathway.
There have been no detailed studies investigating the expression of MR in adrenomedullar cells. PC12 cells have been widely utilized to investigate adrenal catecholamine biosynthesis, chromaffin cell proliferation, and differentiation. We here uncovered the expression of MR in undifferentiated stages of PC12 cells lacking neurite outgrowth and rat adrenal medullar tissues. MR activation in PC12 cells plays a pivotal role in the upregulation of TH expression, since a selective MR antagonist, eplerenone, suppressed aldosterone-induced TH expression. Eplerenone inhibition of aldosterone-induced TH expression was not further influenced by cotreatment with RU-486. Likewise, RU-486 effects on dexamethasone-induced TH mRNA were not affected by adding eplerenone. Considering the differences in the maximal effects and EC 50 of dopamine induction between aldosterone and dexamethasone, it is presumable that a divergence in the mechanism of GR and MR actions underlies in the control of TH expression and dopamine synthesis by PC12 cells. Considering the fact that aldosteroneinduced TH expression was also repressed by a translational inhibitor, cycloheximide, genomic MR actions must be functionally involved in modulating TH expression.
In aldosterone-target cells, 11␤-HSD2 plays crucial roles in conferring aldosterone sensitivity on MR by inactivating intracellular glucocorticoids before they occupy MR. It is known that 11␤-HSD2 mRNA and protein are expressed in sheep, rat, and rabbit adrenals (1, 47, 52, 58), although not in mouse adrenal (12) . Roland and Funder (52) also demonstrated the scattered expression of 11␤-HSD2 mRNA throughout rat adrenal with a relatively abundant signal in the zona fasciculata and weak signal in the medulla. 11␤-HSD2 may protect adrenomedullar cells from excessive effects of glucocorticoids on catecholamine induction. The presence of 11␤-HSD2 in the adrenal medulla and PC12 cells also supports our hypothesis that adrenomedullar MR is functionally involved in regulating catecholamine production.
In addition to the genomic actions of aldosterone mediated through regulation of nuclear gene transcription and protein synthesis, aldosterone also elicits rapid, potentially nongenomic responses, including intracellular calcium, PKC, MAPK, Rho-kinase, and PI3K, in a variety of cells (17, 55) . In this regard, classical MR acts primarily as a transcription factor; however, recent evidence has shown that MR may also mediate nongenomic activation of various second-messenger pathways (26) . For instance, MR antagonists block aldosterone-induced activation of ERK1/2 in vascular smooth muscle cells (30) and Chinese hamster ovary cells transfected with human MR (25) , whereas it is also reported that aldosterone actions on ERK1/2 activation were unaffected by MR antagonists in cortical collecting duct cells (53) . MR antagonists enable us to attenuate the rapid aldosterone-induced activation of Ki-RasA (59) and c-Src (8) , which leads to MAPK activation in cardiovascular cells. MR antagonists are also able to block several nongenomic actions of aldosterone on vascular Na ϩ /K ϩ -ATPase (3) and arterial tone (39, 42, 65) . Hence, the interaction between MR and its nongenomic responses is still controversial.
In this study, aldosterone induced a rapid phosphorylation of the SAPK/JNK pathway. Aldosterone induced p54-SAPK/JNK phosphorylation in PC12 cells, which was further enhanced by BMP-4 treatment. The p46-SAPK/JNK phosphorylation was upregulated by BMP-4 treatment, which was further enhanced by aldosterone action. Thus, aldosterone in combination with BMP-4 stimulates p54/p46-SAPK/JNK pathway in PC12 cells. Mammalian SAPK/JNK proteins are encoded by three genes: jnk1, jnk2, and jnk3. The jnk1 and jnk2 genes are ubiquitously expressed, but jnk3 gene is expressed primarily in the brain. The jnk genes are spliced alternatively to create 10 isoforms, in which spliced variants at the COOH terminus lead to proteins that are either p46 (SAPK/JNK1) or p54 (SAPK/JNK2) in size (29) . Similarly to other MAPK pathways, the JNKs require phosphorylation via an upstream kinase cascade to become active. The SAPK/JNK group is strongly activated by proinflammatory cytokines or extracellular stresses such as irradiation and heat shock and plays important roles in regulating various cellular functions, including proliferation, development, and apoptosis (13) . Both SAPK/JNK1 and SAPK/JNK2 contribute to cellular SAPK/JNK activity in response to various stimuli, and these proteins not only have shared biological functions but also elicit distinct or even opposing biological functions (38, 66) .
Since the inhibition of SAPK/JNK pathway suppressed aldosterone-induced TH expression, rapid nongenomic effects of aldosterone mediated by SAPK/JNK signaling seem functionally involved in the TH expression. Involvement of SAPK/ JNK and PKC pathways in catecholamine biosynthesis is also reported in PC12 cells treated with prolactin-releasing peptide (46) . Given the finding that cotreatment of either eplerenone or cycloheximide in combination with SP600125 restored aldosterone-induced TH expression to the basal levels, both MRmediated genomic actions and nongenomic actions through SAPK/JNK signaling appeared to be linked to aldosteroneinduced catecholamine production.
We reported previously that glucocorticoid and endogenous BMP system are functionally involved in regulating catecholamine biosynthesis in adrenomedullar cells (32) . Other studies have also demonstrated that BMPs regulate sympathetic neuronal differentiation into the adrenergic phenotype (51), in which BMP-4 and BMP-7 induce THimmunoreactive adrenergic phenotype in neural crest cells (68) . However, the physiological roles of BMPs in regulation of neuroendocrine dynamics after phenotypic maturation of sympathoadrenal neurons remain to be elucidated. In the present study, it was of note that both BMP-4 and BMP-7 accelerated aldosterone-induced dopamine production. BMP-4 preferentially increased aldosterone-stimulated TH expression, although BMP-4 and BMP-7 alone had no specific effects on TH and MR expression. Eplerenone abolished BMP-4 enhancement of aldosterone-induced dopamine production and TH expression, suggesting that BMP-4 facilitates the actions mediated via MR. In addition, BMP-4 expression in PC12 cells was not downregulated by aldosterone or dexamethasone, suggesting the bioavailability of endogenous BMP-4 regardless of MR or GR activation. Taking into consideration our finding that eplerenone also reduced BMP-4 effects on aldosterone-induced activation of SAPK/JNK signaling (data not shown), BMP-4 is most likely to facilitate MR-mediated nongenomic actions through activating SAPK/JNK, leading to augmentation of aldosterone-induced dopamine production and TH expression.
Small GTP-binding proteins exist in an inactive GDP-bound cytosolic form, and upon cellular activation they exchange GTP and translocate to the active membrane form. Posttrans- Fig. 9 . Effects of BMP-4 on Aldo-induced activation of Rho-SAPK/JNK pathway in PC12 cells. A: after preculture, cells were incubated with Aldo (100 nM), BMP-4 (100 ng/ml), and SP600125 (10 M) either alone or with indicated combinations. After Aldo was added for 10 -60 min, cells were lysed and subjected to SDS-PAGE/IB analysis using anti-phospho-SAPK/JNK (pSAPK/JNK) and anti-total-SAPK/JNK (tSAPK/JNK) antibodies that detect phosphorylated MAPK signaling. The results shown are representative of those obtained from 3 independent experiments of 30-min exposure with Aldo. The relative integrated density of each protein band (p54-and p46-SAPK/JNK) was digitized by National Institutes of Health (NIH) Image J 1.34s. Results are shown as means Ϯ SE of data from at least 3 separate experiments, each performed with triplicate samples. *P Ͻ 0.05 and **P Ͻ 0.01 vs. untreated control in each group or between the indicated groups. B: cells were incubated with Aldo (100 nM) or Dex (1 M) in combination with BMP-4 (100 ng/ml). After Aldo was added for 60 min, total cellular protein and the membrane fractions were extracted and then subjected to IB analysis using anti-RhoA antibody. The results shown are representative of those obtained from 3 independent experiments. The relative integrated density of each protein band was digitized by NIH Image J 1.34s. Results are shown as means Ϯ SE of data from at least 3 separate experiments, each performed with triplicate samples. *P Ͻ 0.05 and **P Ͻ 0.01 vs. untreated control or between the indicated groups.
lational modification of various small GTP-binding proteins, including Ras and Ras-like proteins such as Rho, Rac, and Rab (10) , is known to interact with the downstream MAPKs and plays a central role in cellular responses such as cell proliferation, differentiation, apoptosis, migration, contraction, and regulation of gene transcription (23, 37, 50) . Activated Ras/ Rho proteins are key components in signal-transducing kinase cascades, including MAPKs (57). In particular, RhoA directly binds to the MAP/ERK kinase kinase-1 (MEKK1), a kinase that activates the ERK and SAPK/JNK pathways (19) . MEKK1 acts as a scaffold element for RhoA signaling to SAPK/JNK pathway.
In our study, aldosterone-induced RhoA activation is enhanced by BMP-4 in PC12 cells. The inhibition of Rho activity by toxin B significantly suppressed TH mRNA levels induced by cotreatment with aldosterone and BMP-4, which mimicked the effect of SAPK/JNK inhibitor SP600125 on reducing TH expression. Therefore, membrane Rho and SAPK/JNK pathway are functionally linked to TH expression induced by aldosterone and BMP-4. The anchoring of small GTP-binding proteins to cell membranes also requires prenylation, in which Rho proteins are modified with geranylgeranylation (37) . Given that inhibition of geranylgeranylation by GGTI-298 did not affect the TH expression induced by aldosterone and BMP-4 in the present study, the prenylation process presumably accounts less for the TH upregulation induced by aldosterone and BMP-4 by PC12 cells. Future investigation is necessary to elucidate the underlying molecular interaction by which aldosterone and BMP-4 elicit activation of Rho-to-SAPK/JNK cascade.
Collectively, a novel functional interrelationship between aldosterone and BMP system in regulating catecholamine production in undifferentiated PC12 cells was demonstrated by the present studies (Fig. 11) . Aldosterone stimulated dopamine production and TH mRNA expression through MR-mediated genomic actions and partly through nongenomic actions of Rho-to-SAPK/JNK pathways. BMP-4 augmented aldosterone-induced dopamine production and TH expression by upregulating nongenomic actions through rapid activation of Rho-SAPK/JNK pathways, at least in part, via MR. Brown et al. (7) also reported that 11 oxygenated steroids, including aldosterone and dexamethasone, increase intracellular dopamine and noradrenaline levels using primary culture of adrenal pheochromocytoma cells from human subjects. Since chromaffin cells are exposed to various hormones produced from neighboring adrenocortical cells within the adrenal, one may consider that not only glucocorticoids but also mineralocorticoids influence hormonal properties of chromaffin cells in relation to this functional cross-talk between MR and endogenous BMP system expressed in adrenomedullar tissues.
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This work was supported in part by Grants-in-Aid for Scientific Research, the Ichiro Kanahara Foundation, the Kato Memorial Bioscience Foundation, the Terumo Lifescience Foundation, and the Naito Foundation. Fig. 11 . A possible mechanism of BMP-4 and aldosterone-induced catecholamine production in the adrenomedullar cells. Aldosterone stimulated dopamine production and TH mRNA expression through genomic and nongenomic actions, including MR-dependent and -independent SAPK/JNK signaling. BMP-4 enhanced aldosterone-induced dopamine production and TH mRNA expression via MR by upregulating nongenomic actions through Rho-SAPK/ JNK pathways. 5 viable cells) were treated with Aldo (100 nM) and BMP-4 (100 ng/ml) in combination with SP600125, Clostridium difficile toxin B, or GGTI-298. After 24-h culture the medium was removed, and total cellular RNAs were extracted. Steady-state mRNA levels of TH and RPL19 were analyzed by quantitative real-time RT-PCR in the extracted total cellular RNA. The level of TH mRNA expression was standardized by level of RPL19 in each sample. Results are shown as means Ϯ SE of data from at least 3 separate experiments, each performed with triplicate samples. *P Ͻ 0.05 and **P Ͻ 0.01 vs. untreated control in each group or between the indicated groups.
